
1. infect genet evol. 2013 dec;20:239-48. doi: 10.1016/j.meegid.2013.09.011. epub
2013 sep 14.

the evolution diversity low complexity vaccine candidate, merozoite
surface protein 9 (msp-9), plasmodium vivax closely related species.

chenet sm(1), pacheco ma, bacon dj, collins we, barnwell jw, escalante aa.

author information: 
(1)arizona state university, school life sciences, tempe, az, usa; center 
evolutionary medicine informatics, biodesign institute, arizona state
university, tempe, az, usa. electronic address: schenet@asu.edu.

the merozoite surface protein-9 (msp-9) considered target an
anti-malarial vaccine since one many proteins involved the
erythrocyte invasion, critical step parasite life cycle. orthologs
encoding antigen found known species plasmodium
parasitic primates. order characterize investigate extent and
maintenance msp-9 genetic diversity, analyzed dna sequences the
following malaria parasite species: plasmodium falciparum, plasmodium reichenowi,
plasmodium chabaudi, plasmodium yoelii, plasmodium berghei, plasmodium coatneyi, 
plasmodium gonderi, plasmodium knowlesi, plasmodium inui, plasmodium simiovale,
plasmodium fieldi, plasmodium cynomolgi plasmodium vivax evaluated the
signature natural selection msp-9 orthologs. findings suggest 
the gene encoding msp-9 purifying selection p. vivax closely
related species. explored selection affected different regions 
msp-9 comparing polymorphisms p. vivax p. falciparum, found
contrasting patterns two species suggest differences in
functional constraints. observation implies msp-9 orthologs in
human parasites may interact differently host immune response. thus,
studies carried one species cannot directly translated other.

copyright Â© 2013 elsevier b.v. rights reserved.

doi: 10.1016/j.meegid.2013.09.011 
pmcid: pmc4066979
pmid: 24044894  [indexed medline]

